Adipose tissue changes in obesity and the impact on metabolic function

Translational Research

Volumn 164, Issue 4, 2014, Pages 284-292

  Sam, Susan ^a   Mazzone, Theodore ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

Author keywords

ATGL = adipose triglycerol lipase; ATM = adipose tissue macrophage; CLS = crown like structure; CRP = C reactive protein; CT = computed tomography; DM2 = type 2 diabetes; FFA = free fatty acid; HSL = hormone sensitive lipase; IL 6 = interleukin 6; MCP 1 = monocyte chemoattractant protein 1; TNF = tumor necrosis factor alpha

Indexed keywords

ADIPOCYTOKINE; FAT; INSULIN; LIPID;

ADIPOSE TISSUE; BODY FAT DISTRIBUTION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPID METABOLISM; LIPID STORAGE; MACROPHAGE; METABOLIC DISORDER; METABOLISM; NONHUMAN; OBESITY; PRECURSOR; PROTEIN LOCALIZATION; REVIEW; ENERGY METABOLISM; PHYSIOLOGY;

ADIPOSE TISSUE; ENERGY METABOLISM; HUMANS; OBESITY;

EID: 84908053578     PISSN: 19315244     EISSN: 18781810     Source Type: Journal    
DOI: 10.1016/j.trsl.2014.05.008     Document Type: Review

References (130)

1. S.E. Shoelson, J. Lee, and A.B. Goldfine Inflammation and insulin resistance J Clin Invest 116 2006 1793 1801
2. G.S. Hotamisligil Inflammation and metabolic disorders Nature 444 2006 860 867
3. S. Schenk, M. Saberi, and J.M. Olefsky Insulin sensitivity: modulation by nutrients and inflammation J Clin Invest 118 2008 2992 3002
4. K. Sun, C.M. Kusminski, and P.E. Scherer Adipose tissue remodeling and obesity J Clin Invest 121 2011 2094 2101
5. C.N. Lumeng, and A.R. Saltiel Inflammatory links between obesity and metabolic disease J Clin Invest 121 2011 2111 2117
6. H. Xu, G.T. Barnes, and Q. Yang Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance J Clin Invest 112 2003 1821 1830
7. S.P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R.L. Leibel, and A.W. Ferrante Jr. Obesity is associated with macrophage accumulation in adipose tissue J Clin Invest 112 2003 1796 1808
8. R. Feinstein, H. Kanety, M.Z. Papa, B. Lunenfeld, and A. Karasik Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates J Biol Chem 268 1993 26055 26058
9. R. Cancello, J. Tordjman, and C. Poitou Increased infiltration of macrophages in omental adipose tissue is associated with marked hepatic lesions in morbid human obesity Diabetes 55 2006 1554 1561
10. C.N. Lumeng, J.L. Bodzin, and A.R. Saltiel Obesity induces a phenotypic switch in adipose tissue macrophage polarization J Clin Invest 117 2007 175 184
11. R. Cancello, C. Henegar, and N. Viguerie Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss Diabetes 54 2005 2277 2286
12. J.M. Wentworth, G. Naselli, and W.A. Brown Pro-inflammatory CD11c+CD206+ adipose tissue macrophages are associated with insulin resistance in human obesity Diabetes 59 2010 1648 1656
13. P. Li, M. Lu, and M.T. Nguyen Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice J Clin Invest 285 2010 15333 15345
14. S. Hocking, D. Samocha-Bonet, K.L. Milner, J.R. Greenfield, and D.J. Chisholm Adiposity and insulin resistance in humans: the role of the different tissue and cellular lipid depots Endocr Rev 34 2013 463 500
15. J.M. Bruun, J.W. Helge, B. Richelsen, and B. Stallknecht Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects Am J Physiol Endocrinol Metab 290 2006 E961 E967
16. S. Cinti, G. Mitchell, and G. Barbatelli Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans J Lipid Res 46 2005 2347 2355
17. K.J. Strissel, Z. Stancheva, and H. Miyoshi Adipocyte death, adipose tissue remodeling, and obesity complications Diabetes 56 2007 2910 2918
18. N. Kloting, M. Fasshauer, and A. Dietrich Insulin-sensitive obesity Am J Physiol Endocrinol Metab 299 2010 E506 E515
19. Z.H. Huang, B. Manickam, and V. Ryvkin PCOS is associated with increased CD11c expression and crown-like structures in adipose tissue and increased central abdominal fat depots independent of obesity J Clin Endocrinol Metab 98 2012 E17 24
20. C.S. Tam, A. Viardot, and K. Clement Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans Diabetes 59 2010 2164 2170
21. M.E. Shaul, G. Bennett, K.J. Strissel, A.S. Greenberg, and M.S. Obin Dynamic, M2-like remodeling phenotypes of CD11c+ adipose tissue macrophages during high-fat diet-induced obesity in mice Diabetes 59 2010 1171 1181
22. J. Aron-Wisnewsky, J. Tordjman, and C. Poitou Human adipose tissue macrophages: M1 and M2 cell surface markers in subcutaneous and omental depots and after weight loss J Clin Endocrinol Metab 94 2009 4619 4623
23. M. Spencer, A. Yao-Borengasser, and R. Unal Adipose tissue macrophages in insulin-resistant subjects are associated with collagen VI and fibrosis and demonstrate alternative activation Am J Physiol Endocrinol Metab 299 2010 E1016 E1027
24. D. Patsouris, P.P. Li, D. Thapar, J. Chapman, J.M. Olefsky, and J.G. Neels Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals Cell Metab 8 2008 301 309
25. H. Wu, X.D. Perrard, and Q. Wang CD11c expression in adipose tissue and blood and its role in diet-induced obesity Arterioscler Thromb Vasc Biol 30 2010 186 192
26. T. Tao, S. Li, A. Zhao, Z. Yanyun, and W. Liu Expression of the CD11c gene in subcutaneous adipose tissue is associated with cytokine level and insulin resistance in women with polycystic ovary syndrome Eur J Endocrinol 167 2012 705 713
27. M. Pasarica, O.R. Sereda, and L.M. Redman Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response Diabetes 58 2009 718 725
28. M. Spencer, R. Unal, and B. Zhu Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance J Clin Endocrinol Metab 96 2011 E1990 E1998
29. N. Hosogai, A. Fukuhara, and K. Oshima Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation Diabetes 56 2007 901 911
30. J. Ye, Z. Gao, J. Yin, and Q. He Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice Am J Physiol Endocrinol Metab 293 2007 E1118 E1128
31. B. Chen, K.S. Lam, and Y. Wang Hypoxia dysregulates the production of adiponectin and plasminogen activator inhibitor-1 independent of reactive oxygen species in adipocytes Biochem Biophys Res Commun 341 2006 549 556
32. N. Halberg, T. Khan, and M.E. Trujillo Hypoxia-inducible factor 1alpha induces fibrosis and insulin resistance in white adipose tissue Mol Cell Biol 29 2009 4467 4483
33. K. Sun, N. Halberg, M. Khan, U.J. Magalang, and P.E. Scherer Selective inhibition of hypoxia-inducible factor 1alpha ameliorates adipose tissue dysfunction Mol Cell Biol 33 2012 904 917
34. G.S. Hotamisligil Endoplasmic reticulum stress and the inflammatory basis of metabolic disease Cell 140 2010 900 917
35. N. Houstis, E.D. Rosen, and E.S. Lander Reactive oxygen species have a causal role in multiple forms of insulin resistance Nature 440 2006 944 948
36. G.S. Hotamisligil, N.S. Shargill, and B.M. Spiegelman Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance Science 259 1993 87 91
37. F. Ofei, S. Hurel, J. Newkirk, M. Sopwith, and R. Taylor Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM Diabetes 45 1996 881 885
38. H. Dominguez, H. Storgaard, and C. Rask-Madsen Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetes J Vasc Res 42 2005 517 525
39. T.L. Stanley, M.V. Zanni, and S. Johnsen TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome J Clin Endocrinol Metab 96 2011 E146 E150
40. P. Plomgaard, K. Bouzakri, R. Krogh-Madsen, B. Mittendorfer, J.R. Zierath, and B.K. Pedersen Tumor necrosis factor-alpha induces skeletal muscle insulin resistance in healthy human subjects via inhibition of Akt substrate 160 phosphorylation Diabetes 54 2005 2939 2945
41. J.T. Willerson, and P.M. Ridker Inflammation as a cardiovascular risk factor Circulation 109 21 Suppl 1 2004 II2 10
42. J. Danesh, R. Collins, P. Appleby, and R. Peto Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies JAMA 279 1998 1477 1482
43. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
44. M.A. Albert, R.J. Glynn, and P.M. Ridker Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score Circulation 108 2003 161 165
45. C.S. Park, S.H. Ihm, and K.D. Yoo Relation between C-reactive protein, homocysteine levels, fibrinogen, and lipoprotein levels and leukocyte and platelet counts, and 10-year risk for cardiovascular disease among healthy adults in the USA Am J Cardiol 105 2010 1284 1288
46. N. Sattar, A. Gaw, and O. Scherbakova Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study Circulation 108 2003 414 419
47. G. Fantuzzi, and T. Mazzone Adipose tissue and atherosclerosis: exploring the connection Arterioscler Thromb Vasc Biol 27 2007 996 1003
48. M. Romano, M.T. Guagnano, and G. Pacini Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women J Clin Endocrinol Metab 88 2003 5321 5326
49. A.W. Taylor, N.O. Ku, and R.F. Mortensen Regulation of cytokine-induced human C-reactive protein production by transforming growth factor-beta J Immunol 145 1990 2507 2513
50. N. Rasouli, and P.A. Kern Adipocytokines and the metabolic complications of obesity J Clin Endocrinol Metab 93 11 Suppl 1 2008 S64 73
51. G. Fantuzzi Adiponectin and inflammation: consensus and controversy J Allergy Clin Immunol 121 2008 326 330
52. A.T. Turer, A. Khera, and C.R. Ayers Adipose tissue mass and location affect circulating adiponectin levels Diabetologia 54 2011 2515 2524
53. S. Li, H.J. Shin, E.L. Ding, and R.M. van Dam Adiponectin levels and risk of type 2 diabetes: a systematic review and meta-analysis JAMA 302 2009 179 188
54. T. Yamauchi, J. Kamon, and Y. Minokoshi Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase Nat Med 8 2002 1288 1295
55. W.L. Holland, R.A. Miller, and Z.V. Wang Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin Nat Med 17 2010 55 63
56. J.Y. Xia, T.S. Morley, and P.E. Scherer The adipokine/ceramide axis: key aspects of insulin sensitization Biochimie 96 2014 130 139
57. H. Yaghootkar, C. Lamina, and R.A. Scott Mendelian randomization studies do not support a causal role for reduced circulating adiponectin levels in insulin resistance and type 2 diabetes Diabetes 62 2013 3589 3598
58. R.Z. Yang, M.J. Lee, and H. Hu Identification of omentin as a novel depot-specific adipokine in human adipose tissue: possible role in modulating insulin action Am J Physiol Endocrinol Metab 290 2006 E1253 E1261
59. C.M. Steppan, S.T. Bailey, and S. Bhat The hormone resistin links obesity to diabetes Nature 409 2001 307 312
60. Q. Yang, T.E. Graham, and N. Mody Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes Nature 436 2005 356 362
61. A. Fukuhara, M. Matsuda, and M. Nishizawa Visfatin: a protein secreted by visceral fat that mimics the effects of insulin Science 307 2005 426 430
62. M.F. Hivert, L.M. Sullivan, and C.S. Fox Associations of adiponectin, resistin, and tumor necrosis factor-alpha with insulin resistance J Clin Endocrinol Metab 93 2008 3165 3172
63. J. Janke, S. Engeli, and M. Boschmann Retinol-binding protein 4 in human obesity Diabetes 55 2006 2805 2810
64. A. Fukuhara, M. Matsuda, and M. Nishizawa Retraction Science 318 2007 565
65. P. Arner, and K.L. Spalding Fat cell turnover in humans Biochem Biophys Res Commun 396 2010 101 104
66. R.A. Klein, D. Halliday, and P.G. Pittet The use of 13-methyltetradecanoic acid as an indicator of adipose tissue turnover Lipids 15 1980 572 579
67. P. Arner, S. Bernard, and M. Salehpour Dynamics of human adipose lipid turnover in health and metabolic disease Nature 478 2011 110 113
68. P. Belfrage, B. Jergil, P. Stralfors, and H. Tornqvist Identification and some characteristics of the enzyme protein of the hormone-sensitive lipase from rat adipose tissue Adv Exp Med Biol 101 1978 113 126
69. G. Haemmerle, R. Zimmermann, and J.G. Strauss Hormone-sensitive lipase deficiency in mice changes the plasma lipid profile by affecting the tissue-specific expression pattern of lipoprotein lipase in adipose tissue and muscle J Biol Chem 277 2002 12946 12952
70. R. Zimmermann, J.G. Strauss, and G. Haemmerle Fat mobilization in adipose tissue is promoted by adipose triglyceride lipase Science 306 2004 1383 1386
71. G. Fredrikson, H. Tornqvist, and P. Belfrage Hormone-sensitive lipase and monoacylglycerol lipase are both required for complete degradation of adipocyte triacylglycerol Biochim Biophys Acta 876 1986 288 293
72. D. Langin, A. Dicker, and G. Tavernier Adipocyte lipases and defect of lipolysis in human obesity Diabetes 54 2005 3190 3197
73. P. Arner, D.P. Andersson, and A. Thorne Variations in the size of the major omentum are primarily determined by fat cell number J Clin Endocrinol Metab 98 2013 E897 901
74. L. Hellstrom, D. Langin, S. Reynisdottir, M. Dauzats, and P. Arner Adipocyte lipolysis in normal weight subjects with obesity among first-degree relatives Diabetologia 39 1996 921 928
75. J.W. Jocken, D. Langin, and E. Smit Adipose triglyceride lipase and hormone-sensitive lipase protein expression is decreased in the obese insulin-resistant state J Clin Endocrinol Metab 92 2007 2292 2299
76. J. Berndt, S. Kralisch, and N. Kloting Adipose triglyceride lipase gene expression in human visceral obesity Exp Clin Endocrinol Diabetes 116 2008 203 210
77. P. Mauriege, J.P. Despres, and D. Prud'homme Regional variation in adipose tissue lipolysis in lean and obese men J lipid Res 32 1991 1625 1633
78. K.L. Spalding, E. Arner, and P.O. Westermark Dynamics of fat cell turnover in humans Nature 453 2008 783 787
79. E. Ehrenborg, S.M. Clee, and S.N. Pimstone Ethnic variation and in vivo effects of the -93t - >g promoter variant in the lipoprotein lipase gene Arterioscler Thromb Vasc Biol 17 1997 2672 2678
80. R. Jemaa, S. Tuzet, C. Portos, D. Betoulle, M. Apfelbaum, and F. Fumeron Lipoprotein lipase gene polymorphisms: associations with hypertriglyceridemia and body mass index in obese people Int J Obes Relat Metab Disord 19 1995 270 274
81. V. Radha, K.S. Vimaleswaran, K.A. Ayyappa, and V. Mohan Association of lipoprotein lipase gene polymorphisms with obesity and type 2 diabetes in an Asian Indian population Int J Obes (Lond) 31 2007 913 918
82. C.N. Sadur, T.J. Yost, and R.H. Eckel Insulin responsiveness of adipose tissue lipoprotein lipase is delayed but preserved in obesity J Clin Endocrinol Metab 59 1984 1176 1182
83. D.H. Bessesen, A.D. Robertson, and R.H. Eckel Weight reduction increases adipose but decreases cardiac LPL in reduced-obese Zucker rats Am J Physiol 261 2 Pt 1 1991 E246 E251
84. R.H. Eckel, and T.J. Yost Weight reduction increases adipose tissue lipoprotein lipase responsiveness in obese women J Clin Invest 80 1987 992 997
85. R.S. Schwartz, and J.D. Brunzell Increase of adipose tissue lipoprotein lipase activity with weight loss J Clin Invest 67 1981 1425 1430
86. R.H. Eckel, T.J. Yost, and D.R. Jensen Sustained weight reduction in moderately obese women results in decreased activity of skeletal muscle lipoprotein lipase Eur J Clin Invest 25 1995 396 402
87. K.M. Rexrode, V.J. Carey, and C.H. Hennekens Abdominal adiposity and coronary heart disease in women JAMA 280 1998 1843 1848
88. S. Yusuf, S. Hawken, and S. Ounpuu Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study Lancet 366 2005 1640 1649
89. D. Canoy, S.M. Boekholdt, and N. Wareham Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: a population-based prospective study Circulation 116 2007 2933 2943
90. J.P. Despres, I. Lemieux, and J. Bergeron Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk Arterioscler Thromb Vasc Biol 28 2008 1039 1049
91. I. Lemieux, A. Pascot, and C. Couillard Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? Circulation 102 2000 179 184
92. S. Sam, S. Haffner, and M.H. Davidson Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes Diabetes Care 32 2009 1916 1920
93. M.A. Banerji, J. Lebowitz, R.L. Chaiken, D. Gordon, J.G. Kral, and H.E. Lebovitz Relationship of visceral adipose tissue and glucose disposal is independent of sex in black NIDDM subjects Am J Physiol 273 2 Pt 1 1997 E425 E432
94. Y. Miyazaki, L. Glass, C. Triplitt, E. Wajcberg, L.J. Mandarino, and R.A. DeFronzo Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus Am J Physiol Endocrinol Metab 283 2002 E1135 E1143
95. A. Gastaldelli, K. Cusi, and M. Pettiti Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects Gastroenterology 133 2007 496 506
96. G.A. Bray, K.A. Jablonski, and W.Y. Fujimoto Relation of central adiposity and body mass index to the development of diabetes in the Diabetes Prevention Program Am J Clin Nutr 87 2008 1212 1218
97. B.J. Nicklas, B.W. Penninx, A.S. Ryan, D.M. Berman, N.A. Lynch, and K.E. Dennis Visceral adipose tissue cutoffs associated with metabolic risk factors for coronary heart disease in women Diabetes Care 26 2003 1413 1420
98. T. Aaltonen, A. Abulencia, and J. Adelman Search for exclusive gamma gamma production in Hadron-Hadron collisions Phys Rev Lett 99 2007 242002
99. C.S. Fox, J.M. Massaro, and U. Hoffmann Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study Circulation 116 2007 39 48
100. K.M. Pou, J.M. Massaro, and U. Hoffmann Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study Circulation 116 2007 1234 1241
101. A. Basu, R. Basu, P. Shah, A. Vella, R.A. Rizza, and M.D. Jensen Systemic and regional free fatty acid metabolism in type 2 diabetes Am J Physiol 280 2001 E1000 E1006
102. N. Abate, A. Garg, R.M. Peshock, J. Stray-Gundersen, B. Adams-Huet, and S.M. Grundy Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM Diabetes 45 1996 1684 1693
103. N. Abate, A. Garg, R.M. Peshock, J. Stray-Gundersen, and S.M. Grundy Relationships of generalized and regional adiposity to insulin sensitivity in men J Clin Invest 96 1995 88 98
104. M.D. Jensen Role of body fat distribution and the metabolic complications of obesity J Clin Endocrinol Metab 93 11 Suppl 1 2008 S57 63
105. P. Arner Not all fat is alike Lancet 351 1998 1301 1302
106. K. Rebrin, G.M. Steil, S.D. Mittelman, and R.N. Bergman Causal linkage between insulin suppression of lipolysis and suppression of liver glucose output in dogs J Clin Invest 98 1996 741 749
107. R.N. Bergman, and M. Ader Free fatty acids and pathogenesis of type 2 diabetes mellitus Trends Endocrinol Metab 11 2000 351 356
108. S. Nielsen, Z. Guo, C.M. Johnson, D.D. Hensrud, and M.D. Jensen Splanchnic lipolysis in human obesity J Clin Invest 113 2004 1582 1588
109. S.K. Fried, D.A. Bunkin, and A.S. Greenberg Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid J Clin Endocrinol Metab 83 1998 847 850
110. J.M. Bruun, A.S. Lihn, S.B. Pedersen, and B. Richelsen Monocyte chemoattractant protein-1 release is higher in visceral than subcutaneous human adipose tissue (AT): implication of macrophages resident in the AT J Clin Endocrinol Metab 90 2005 2282 2289
111. M.C. Alessi, F. Peiretti, P. Morange, M. Henry, G. Nalbone, and I. Juhan-Vague Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease Diabetes 46 1997 860 867
112. A. Festa, R. D'Agostino Jr., and K. Williams The relation of body fat mass and distribution to markers of chronic inflammation Int J Obes Relat Metab Disord 25 2001 1407 1415
113. I. Lemieux, A. Pascot, and D. Prud'homme Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity Arterioscler Thromb Vasc Biol 21 2001 961 967
114. L. Fontana, J.C. Eagon, M.E. Trujillo, P.E. Scherer, and S. Klein Visceral fat adipokine secretion is associated with systemic inflammation in obese humans Diabetes 56 2007 1010 1013
115. I. Harman-Boehm, M. Bluher, and H. Redel Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity J Clin Endocrinol Metab 92 2007 2240 2247
116. A.S. Lihn, J.M. Bruun, G. He, S.B. Pedersen, P.F. Jensen, and B. Richelsen Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects Mol Cell Endocrinol 219 2004 9 15
117. E. Fabbrini, F. Magkos, and B.S. Mohammed Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity Proc Natl Acad Sci U S A 106 2009 15430 15435
118. R.P. Wildman, P. Muntner, and K. Reynolds The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004) Arch Intern Med 168 2008 1617 1624
119. N. Stefan, K. Kantartzis, and J. Machann Identification and characterization of metabolically benign obesity in humans Arch Intern Med 168 2008 1609 1616
120. A. Garg Acquired and inherited lipodystrophies N Engl J Med 350 2004 1220 1234
121. H. Bays, L. Mandarino, and R.A. DeFronzo Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach J Clin Endocrinol Metab 89 2004 463 478
122. H.E. Bays, J.M. Gonzalez-Campoy, and G.A. Bray Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity Expert Rev Cardiovasc Ther 6 2008 343 368
123. J.M. Lehmann, L.B. Moore, T.A. Smith-Oliver, W.O. Wilkison, T.M. Willson, and S.A. Kliewer An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma) J Biol Chem 270 1995 12953 12956
124. Y.X. Wang PPARs: diverse regulators in energy metabolism and metabolic diseases Cell Res 20 2010 124 137
125. K. Reue The lipin family: mutations and metabolism Curr Opin Lipidol 20 2009 165 170
126. A. Yao-Borengasser, N. Rasouli, and V. Varma Lipin expression is attenuated in adipose tissue of insulin-resistant human subjects and increases with peroxisome proliferator-activated receptor gamma activation Diabetes 55 2006 2811 2818
127. K.A. Fawcett, N. Grimsey, and R.J. Loos Evaluating the role of LPIN1 variation in insulin resistance, body weight, and human lipodystrophy in U.K. populations Diabetes 57 2008 2527 2533
128. K.S. Burgdorf, C.H. Sandholt, and T. Sparso Studies of association between LPIN1 variants and common metabolic phenotypes among 17,538 Danes Eur J Endocrinol 163 2010 81 87
129. J.A. Menendez, A. Vazquez-Martin, F.J. Ortega, and J.M. Fernandez-Real Fatty acid synthase: association with insulin resistance, type 2 diabetes, and cancer Clin Chem 55 2009 425 438
130. O. Gealekman, N. Guseva, and C. Hartigan Depot-specific differences and insufficient subcutaneous adipose tissue angiogenesis in human obesity Circulation 123 2011 186 194